Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Alico Pitches Florida Land Pivot as Citrus Exit Unlocks Real Estate Value

Alico (NASDAQ:ALCO) is positioning itself as a diversified Florida land and real estate company after winding down its legacy citrus operations, a company representative told investors during a recent presentation. The representative said Alico has been public since 1960 and listed on the Nasdaq si

MarketBeat

Stocks Pressured by a Rebound in Crude Prices and Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.20%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.57%. June E-mini S&P futures (ESM26 ) are down -0.28%, and June E-mini Nasdaq futures...

Barchart

5 Robotics Stocks to Watch as Physical AI Builds Momentum

As AI moves from the digital world into the physical one, robotics stocks are emerging as one of the market's most compelling early-stage opportunities.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

TOYO Q1 Earnings Call Highlights

TOYO (NASDAQ:TOYO) reported a sharply improved first quarter for fiscal 2026, with management describing the period as an “inflection point” as higher solar cell and module shipments drove record revenue, gross profit and net income. Chairman and Chief Executive Officer Takahiko Onozuka said revenu

MarketBeat

Compugen Q1 Earnings Call Highlights

Compugen (NASDAQ:CGEN) said it remains on track to report interim progression-free survival data in the first quarter of 2027 from its MAIA-ovarian study, as the clinical-stage immuno-oncology company outlined first-quarter 2026 results and updates across its internal and partnered programs. On the

MarketBeat

Baidu Q1 Earnings Call Highlights

Baidu (NASDAQ:BIDU) reported a return to revenue growth in its first quarter of 2026, with management emphasizing that artificial intelligence has become the company’s primary growth engine and now accounts for a majority of its general business revenue. Co-founder and Chief Executive Robin Li said

MarketBeat

Stocks Mixed as Crude Oil Prices and Bond Yields Fall

The S&P 500 Index ($SPX ) (SPY ) today is up +0.07%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.25%. June E-mini S&P futures (ESM26 ) are up +0.10%, and June E-mini Nasdaq futures...

Barchart

Read news from The Economist, FT, and more,
with one subscription

Insider Buying Says Upstart Isn’t Down for the Count

Upstart is a growing fintech with the potential to accelerate growth and begin taking share from its larger competitors, driven by an AI-powered platform.

MarketBeat

Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus

Insmed (NASDAQ:INSM) Chair and CEO Will Lewis said the company remains confident in the launch trajectory of BRINSUPRI, despite investor concerns over discontinuation rates that followed the company’s latest update. Speaking at a Bank of America healthcare conference, Lewis said the company intended

MarketBeat

Infosys, OFSS, TechM, other IT stocks gain up to 3% despite weak market sentiment. Here's why

IT stocks such as Infosys and Oracle Financial Services Software gained, while LTIMindtree, Coforge, Tech Mahindra, Mphasis and Persistent Systems also posted strong gains. Meanwhile, the BSE Sensex and Nifty 50 dropped over 1% as the rupee hit a record low and bond yields surged to all-time highs.

The Economic Times

Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build

Incyte (NASDAQ:INCY) President and CEO Bill Meury said the company’s post-Jakafi growth profile has become “much clearer” over the past year, pointing to continued growth in its commercial business, late-stage pipeline activity and potential launches across oncology and immunology. Speaking at the

MarketBeat

IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data

IDEAYA Biosciences (NASDAQ:IDYA) said its lead oncology program remains on track for a regulatory submission after reporting positive top-line data in first-line metastatic melanoma, while also highlighting several pipeline programs during a presentation at the Bank of America Global Healthcare Conf

MarketBeat

InterDigital Maps Path to $1B Recurring Revenue on Patents, Streaming Push

InterDigital (NASDAQ:IDCC) Chief Financial Officer Rich Brezski outlined the company’s patent licensing model, recent financial performance and long-term growth targets during a presentation at the 21st Annual Needham Technology, Media, and Consumer Conference. Brezski described InterDigital as “fi

MarketBeat

Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears

Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief executive officer, Chief Financial Officer Lea Knight said during a Bank of America med tech conference discussion hosted by analyst Rei Tan.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness

Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while acknowledging softness in medical tied to a weaker respiratory illness season. Speaking at a Bank of America h

MarketBeat

Horizon Quantum Computing Pte. Lays Out Quantum Software Push at Needham Conference

Horizon Quantum Computing Pte. (NASDAQ:HQ) used its appearance at Needham & Company’s 21st annual Technology, Media, & Consumer Conference to outline its strategy as a newly public quantum software company focused on building infrastructure for developers, hardware providers and end users. Needham

MarketBeat

GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead

GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related to its NHS study, according to comments made by Aaron, who identified himself during the discussion as the company’s CFO, at a Bank of America event. Aaron said t

MarketBeat

Alphabet’s YouTube CEO Touts AI, Creators and TV as Growth Flywheel

YouTube CEO Neal Mohan said the Alphabet (NASDAQ:GOOG) video platform is continuing to lean on creators, subscriptions, connected TV and artificial intelligence as the core drivers of its business, while emphasizing that the company’s overall strategy has remained consistent even as the media indust

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In

Broadcom is surging, and now, private credit behemoths are reportedly in talks to extend funding. See the potential implications of a massive debt deal.

MarketBeat

FOX Sees ‘Focus and Momentum’ as News, Sports and Tubi Gain Ground

John Nallen said FOX (NASDAQ:FOX) is benefiting from a sharper strategic focus than many of its media peers, citing strength in live news, live sports and the company’s ad-supported streaming platform Tubi. Speaking with analyst Robert Fishman, Nallen said the company is in “a really good spot” and

MarketBeat

EverQuote Sees Insurance Carrier Comeback Fueling Growth Toward $1B Revenue

EverQuote (NASDAQ:EVER) Chief Financial Officer Joseph Sanborn said the online insurance marketplace is benefiting from a healthier property and casualty insurance industry as carriers shift from restoring underwriting profitability to pursuing policy growth. Speaking with Needham & Company ana

MarketBeat

Erasca Touts 'Eye-Popping' ERAS-0015 Lung Cancer Data, FDA Path at BofA Conference

Erasca (NASDAQ:ERAS) executives said the company sees multiple potential development paths for its RAS-targeting portfolio, highlighting early clinical activity for ERAS-0015 in lung, pancreatic and colorectal cancers during a Bank of America biotech conference session. Jonathan Lim, Erasca’s chair

MarketBeat

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification

International Business Times

SpaceX Files for the Largest IPO Ever Since Absorbing a $4.94 Billion Loss From Its xAI Merger

A cash-printing satellite network, an entrenched launch monopoly, and a $14-billion-a-year AI furnace are about to be priced under a single ticker. The hard part isn't the size. It's deciding what SpaceX actually is.

MarketBeat

MarketBeat Week in Review – 05/11 - 05/15

Stocks were mostly higher this week as investors were reminded that earnings are the signal; inflation and geopolitics is noise

1 … 10 11 12 13

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations